Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Open in API
Filings indexed 508 across all filing types
Latest filing 2022-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company Helixmith (헬릭스미스) for the 3rd quarter of 2022 (ending 2022-09-30). It contains detailed financial information, business operations, R&D activities, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
투자판단관련주요경영사항(VM202-ALS 임상 2a상 임상시험 Topline data 발표)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system (KIND) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details the topline results of a Phase 2a clinical trial for the drug VM202-ALS. Since this is a specific regulatory disclosure of material information regarding clinical trial results, it falls under the 'Regulatory Filings' category as it does not fit into the specific financial report or corporate governance categories provided.
2022-09-02 Korean
투자판단관련주요경영사항(통증을 동반한 당뇨병성 신경병증(DPN) 치료제(Engensis: VM202) 임상 3-2상 관련 중간 분석 결과)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding a 'major management matter' (투자판단 관련 주요경영사항) concerning the interim analysis results of a Phase 3-2 clinical trial for the drug Engensis (VM202). Since it details clinical trial progress and regulatory committee recommendations rather than a full financial report, dividend, or management change, it falls under the general regulatory filing category.
2022-08-18 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company Helixmith (헬릭스미스) covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial information, business descriptions, management discussions, and organizational data, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean
전환가액의조정(제4회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB). This type of filing, which details changes to capital structure instruments like convertible bonds, falls under the 'Capital/Financing Update' category as it directly relates to financing activities and the terms of debt-to-equity conversion.
2022-08-03 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding capital structure changes and equity-based compensation falls under the category of 'Share Issue/Capital Change' (SHA) within the provided classification schema.
2022-06-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.